Substantia nigra hypoechogenicity: Definition and findings in restless legs syndrome

Movement Disorders

Volumn 22, Issue 2, 2007, Pages 187-192

  Godau, Jana ^a   Schweitzer, Katherine J ^a   Liepelt, Inga ^a   Gerloff, Christian ^b   Berg, Daniela ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Brain iron homeostasis; Restless legs syndrome; Substantia nigra; Substantia nigra iron content; Transcranial sonography

Indexed keywords

DOPAMINE RECEPTOR STIMULATING AGENT; IRON; LEVODOPA;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOPPLER ECHOGRAPHY; FEMALE; HUMAN; IRON DEFICIENCY; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RESTLESS LEGS SYNDROME; SUBSTANTIA NIGRA;

EID: 33847754307     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.21230     Document Type: Article

References (21)

1. Connor JR, Boyer PJ, Menzies SL, et al. Neuropathological examination suggests impaired iron acquisition in restless legs syndrome. Neurology 2003;61:304-309.
2. Connor JR, Wang XS, Patton SM, et al. Decreased transferrin receptor expression by neuromelanin cells in restless legs syndrome. Neurology 2004;62:1563-1567.
3. Allen RP, Barker PB, Wehrl F, Song HK, Earley CJ. MRI measurement of brain iron in patients with RLS. Neurology 2001;56:263-265.
4. Earley CJ, Barker PB, Horska A, Allen RP. MRI-determined regional brain iron concentrations in early- and late-onset restless legs syndrome. Sleep Med 2006;7:458-461.
5. Berg D, Siefker C, Becker G. Echogenicity of the substantia nigra in Parkinson's disease and its relation to clinical findings. J Neurol 2001;248:684-689.
6. Walter U, Wittstock M, Benecke R, Dressler D. Substantia nigra echogenicity is normal in non-extrapyramidal cerebral disorders but increased in Parkinson's disease. J Neural Transm 2002;109:191-196.
7. Zedde M, Manca A, Baule G, Agnetti V. Brain parenchyma sonography (BPS) of substantia nigra (SN) in Parkinson's disease. Parkinsonism Relat Disord 2005;11:222.
8. Becker G, Berg D. Neuroimaging in basal ganglia disorders: perspectives for transcranial ultrasound. Mov Disord 2001;16:23-32.
9. Berg D, Becker G, Zeiler B, et al. Vulnerability of the nigrostriatal system as detected by transcranial ultrasound. Neurology 1999;53:1026-1031.
10. Berg D, Grote C, Rausch WD, et al. Iron accumulation of the substantia nigra in rats visualized by ultrasound. Ultrasound Med Biol 1999;25:901-904.
11. Berg D, Roggendorf W, Schröder U, et al. Echogenicity of the substantia nigra - association with increased iron content and marker for susceptibility to nigrostriatal injury. Arch Neurol 2002;59:999-1005.
12. Zecca L, Berg D, Arzberger T, et al. In vivo detection of iron and neuromelanin by transcranial sonography: a new approach for early detection of substantia nigra damage. Mov Disord 2005;20:1278-1285.
13. Schmidauer C, Sojer M, Seppi K, et al. Transcranial ultrasound shows nigral hypoechogenicity in restless legs syndrome. Ann Neurol 2005;58:630-634.
14. Allen RP, Picchietti D, Hening WA, Trenkwalder C, Walters AS, Montplaisir J; Restless Legs Syndrome Diagnosis and Epidemiology workshop at the National Institutes of Health; International Restless Legs Syndrome Study Group. Restless legs syndrome: diagnostic criteria, special considerations and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med 2003;4:101-119.
15. Allen RP, Earley CJ. Validation of the Johns Hopkins Restless Legs Severity Scale (JHRLSS). Sleep Med 2001;2:239-242.
16. Walters AS, LeBrocq C, Dhar A, et al. Validation of the International Restless Legs Syndrome Study Group rating scale for restless legs syndrome. Sleep Med 2003;4:121-132.
17. Earley CJ, Connor JR, Beard JL, et al. Abnormalities in CSF concentrations of ferritin and transferrin in restless legs syndrome. Neurology 2000;54:1698-1700.
18. Mizuno S, Mihara T, Miyaoka T, Inagaki T, Horiguchi J. CSF iron, ferritin and transferrin levels in restless legs syndrome. J Sleep Res 2005;14:43-47.
19. Clardy SL, Earley CJ, Allen RP, Beard JL, Connor JR. Ferritin subunits in CSF are decreased in restless legs syndrome. J Lab Clin Med 2006;147:67-73.
20. Winkelmann J, Wetter TC, Collado-Seidel V, et al. Clinical characteristics and frequency of the hereditary restless legs syndrome in a population of 300 patients. Sleep 2000;23:597-602.
21. Berg D, Merz B, Reiners K, Naumann M, Becker G. Five-year follow-up study of hyperechogenicity of the substantia nigra in Parkinson's disease. Mov Disord 2005;20:383-385.